drugset / Trial / NCT05028140
Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Piemonte association in the treatment of type 2 diabetes mellitus
Timeline
- Start
- 2024-10-08
- Primary completion
- 2026-07
- Completion
- 2027-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Empagliflozin | Small molecule | 25 mg | Oral |
| Subject | Piemonte association | Unknown | — | Oral |
| Comparator | Pioglitazone | Small molecule | 30 mg | Oral |